| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Bank of N.T. Butterfield & Son (NTB) | Goldman Sachs/ Citigroup/ Sandler O’Neill + Partners | $100.00 | N/C | |||
| N/C = No Call – Stock is traded on the Burnuda Stock Exchange | ||||||
| Postponed | ||||||
| AgEagle Aerial Systems (UAVSU) (u) | Northland Capital Markets | 2.75 | $4.25 | $4.25 | $11.69 | 1-Star |
| Withdrawn | ||||||
| Bioventus (BIOV) | J.P. Morgan/ Piper Jaffray | 8.82 | $16.00 | $18.00 | $150.00 | 1-Star |
| inVentiv Group Holdings (IVH) | Credit Suisse/ Morgan Stanley/ Goldman Sachs/ Jefferies | $100.00 | n.a. | |||
| New Terms | ||||||
| Protagonist Therapeutics (PTGX) | Leerink Partners/ Barclays/ BMO Capital Markets | 5.84 | $11.00 | $13.00 | $70.02 | 1-Star |
| Medpace Holdings (MEDP) | Jefferies/ Credit Suisse/ UBS Investment Bank/ Wells Fargo Securities | 7.00 | $20.00 | $23.00 | $150.50 | 2-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Aug. 1, 2016 | Manager(s) | Offered | Raised | Price | 8/5/16 | Change |
| First Hawaiian (FHB) | Goldman Sachs/ BofA Merrill Lynch/ BNP PARIBAS/ Barclays/ Credit Suisse/ Deutsche Bank Securities/ J.P. Morgan/ Citigroup/ Morgan Stanley/ UBS Investment Bank | 21.09 | $485.00 | $23.00 | $24.84 | 8.00% |
| Atomera (ATMR) | National Securities Corporation | 3.20 | $24.00 | $7.50 | $8.08 | 7.73% |
| At Home Group (HOME) | BofA Merrill Lynch/ Goldman Sachs/ Jefferies/ Morgan Stanley | 8.67 | $130.01 | $15.00 | $15.31 | 2.07% |
| Gemphire Therapeutics (GEMP) | Jefferies/ Cowen and Company | 3.00 | $30.00 | $10.00 | $9.20 | -8.00% |
